GlassScriptPhysician profile
Joshua R Mitchell
NPI 1295969830
$1,539.16
in general payments reported to CMS, 2019-2025
7 companies · $50.61 in 2025
The $50.61 reported for 2025 was less than what a typical Pediatric Otolaryngology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.92 · 2022: $14.36 · 2024: $1,430 · 2025: $50.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,410 · Food and Beverage: $70.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,410.00 |
| Food and Beverage | $70.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $1,410.00 | 2024 | Amvuttra |
| Integra Lifesciences Corporation | $36.94 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Checkpoint Surgical, INC | $22.20 | 2021 | |
| Stryker Corporation | $21.72 | 2021 | |
| Med-El Corporation | $20.27 | 2024 | Bci 602 Kit, Mi1250 Synchrony 2 Flexsoft |
| Cochlear Americas | $14.36 | 2022 | |
| Hologic Sales and Service, LLC | $13.67 | 2025 | Coolseal Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.